IRF2‐binding protein‐1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2‐dependent transcription | Zendy

Kimura Makoto | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

IRF2‐binding protein‐1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2‐dependent transcription

Author(s) -

Kimura Makoto

Publication year - 2008

Publication title -

febs letters

Language(s) - Slovak

Resource type - Journals

SCImago Journal Rank - 1.593

H-Index - 257

eISSN - 1873-3468

pISSN - 0014-5793

DOI - 10.1016/j.febslet.2008.07.033

Subject(s) - transcription factor , ubiquitin ligase , activating transcription factor 2 , transcription (linguistics) , dna binding protein , sp1 transcription factor , corepressor , promoter , microbiology and biotechnology , chemistry , ubiquitin , cancer research , biology , biochemistry , repressor , gene expression , gene , linguistics , philosophy

MINT‐6699624:JDP2 (uniprotkb:Q8WYK2) physically interacts (MI:0218) with Valyl-tRNA synthetase (uniprotkb:P26640), IRF2-BP1 (uniprotkb:Q8IU81), ATF7 (uniprotkb:P17544), EEF1G (uniprotkb:P26641), EEF1A1 (uniprotkb:P68104), JUND (uniprotkb:P17535), JUNB (uniprotkb:P17275), EF1D2 (uniprotkb:P29692) and RPLP0 (uniprotkb:P05388) by anti tag coimmunoprecipitation (MI:0007). MINT‐6699850:JDP2 (uniprotkb:Q8WYK2) binds (MI:0407) to IRF2-BP1 (uniprotkb:Q8IU81) by pull down (MI:0096). MINT‐6699684:JDP2 (uniprotkb:Q8WYK2) physically interacts (MI:0218) with JUNB (uniprotkb:P17275), JUND (uniprotkb:P17535), ATF7 (uniprotkb:P17544) and IRF2-BP1 (uniprotkb:Q8IU81) by anti tag coimmunoprecipitation (MI:0007). MINT‐6699839:IRF2-BP1 (uniprotkb:Q8IU81) physically interacts (MI:0218) with JDP2 (uniprotkb:Q8WYK2) by anti bait coimmunoprecipitation (MI:0006). MINT‐6699748:JDP2 (uniprotkb:Q8WYK2) physically interacts (MI:0218) with ATF2 (uniprotkb:P15336) and c-JUN (uniprotkb:P05412) by anti tag coimmunoprecipitation (MI:0007). MINT‐6699865:ATF2 (uniprotkb:P15336) binds (MI:0407) to IRF2-BP1 (uniprotkb:Q8IU81) by pull down (MI:0096).

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research